Drug Type Small molecule drug |
Synonyms Bufyl |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Molecular FormulaC18H31ClN2O2 |
InChIKeyHUCIWBPMHXGLFM-UHFFFAOYSA-N |
CAS Registry73360-54-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | GB | 01 Jan 2012 |
Not Applicable | 345 | (Group 1) | rjzsckewjv(qsxdppvqeg) = mgxqveuesd oouzqzwjim (gstznzhvgn, pyjltioszq - fzlqebgdrn) View more | - | 05 Apr 2022 | ||
Group 2 (Group 2) | rjzsckewjv(qsxdppvqeg) = hezfbhjibv oouzqzwjim (gstznzhvgn, eegsqkqohr - bwtljiathc) View more | ||||||
Phase 4 | 50 | Holter ECG monitor (General Anesthesia (G)) | tbzyjufhys(khhjpeogjl): P-Value = 0.3861; P-Value = 0.2591 View more | - | 25 Apr 2017 | ||
Holter ECG monitor+Bupivacaine-fentanyl (Combined General/Epidural (G/E)) |